SNY and DNTH Related Headlines

Go Back

Jun 10, 2026 04:10PM Guggenheim Defending Dianthus Therapeutics (DNTH): 'We reiterate our positive view'
Jun 10, 2026 01:37PM Raymond James on Dianthus Therapeutics (DNTH) Amid 15% Down Day: 'We See Overall Positive Readthrough to Claseprubart'
Jun 10, 2026 01:37PM TD Cowen Defending Dianthus Therapeutics (DNTH): 'We see weakness as a buying opportunity'

SNY and DNTH Related Press Releases

Go Back

SNY and DNTH Related SEC Filings

Go Back